PFS Partners »

Engene Therapeutics shares owned by PFS Partners

Quarter-by-quarter ownership of Engene Therapeutics (ENGN) shares owned by PFS Partners from 13F filings

Historical chart of PFS Partners investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by PFS Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by PFS Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 11k 1.73

More positions owned by PFS Partners

Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Innovator Etfs Trust Us Sml Cp Pwr B (KJAN)
Ishares Tr Core Div Grwth (DGRO)
First Tr Exch Traded Fd Iii Shrt Dur Mng Mun (FSMB)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (XMAR)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Innovator Etfs Trust Intrnl Dev Aprl (IAPR)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low (XMLV)
Ishares Tr Core S&p500 Etf (IVV)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Micron Technology (MU)
American Intl Group Com New (AIG)
First Tr Exchange-traded Ft Vest S&p 500 (KNG)

View all positions for PFS Partners

Top funds holding Engene Therapeutics

BML Capital Management
Siren
Perceptive Advisors
Ameriprise Financial
Nextech Invest
ADAR1 Capital Management
Vestal Point Capital
Acorn Capital Advisors
Peapod Lane Capital
Balyasny Asset Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Affinity Asset Advisors
UBS Group

View all funds holding Engene Therapeutics